ORAMED PHARMACEUTICALS, INC. |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-15 | Compugen Names David Silberman CFO | MT |
| 05-09 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Oramed Pharmaceuticals, Inc.
68000c513f91d81b05021fc1a.ONUL1RGZ2axFpRU5ejZs0M84dg3pk0ENB_dAXTrurVE.VoZIvGTr9P4qkEIAFVonvIdhJGCCyTh5ZL0uG0286xBimHKyRvGIlBbWXA~7c547abec1e52fa6f84cbdc507a9c2b8
Past events on Oramed Pharmaceuticals, Inc.
| 2023-07-13 09:00 | Annual General Meeting |
| 2023-06-23 18:15 | American Diabetes Association Scientific Session |
| 2023-05-31 13:30 | Novel Therapies for Diabetes & Obesity Summit |
| 2023-05-10 | Q1 2023 Earnings Release |
| 2022-12-07 13:30 | Planet MicroCap Showcase |
| 2022-11-17 11:00 | ORMD-0801 Phase 2 Trial Results Call |
| 2022-11-10 16:30 | Q3 2022 Earnings Release |
| 2022-09-13 15:00 | H.C. Wainwright Global Investment Conference |
| 2022-08-10 16:30 | Canaccord Growth Conference |
| 2022-06-30 09:00 | Annual General Meeting |
| 2022-05-25 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-03-30 12:00 | Investor Meeting - Key Opinion Leader |
| 2022-03-15 15:50 | Barclays Global Healthcare Conference |
| 2022-02-24 09:30 | Aegis Capital Virtual Summit |
| 2022-01-04 | LifeSci Partners Corporate Access Event |
| 2021-11-24 | FY 2021 Earnings Release |
| 2021-11-18 11:00 | Oravax Medical Inc and Genomma Lab 50/50 Joint Venture Agreement Call |
| 2021-11-15 11:30 | H.C. Wainwright Israel Conference |
| 2021-09-30 12:00 | Cantor Fitzgerald Global Healthcare Conference |
| 2021-09-13 07:00 | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,70 2,70 0.22% | 2,71 3,96 -31.48% | 0,90 | 2,70 2,76 -2.24% | 1,34 1,32 1.52% | 1,50 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,6 -16,7 12.58% | -11,8 -16,9 30.42% | 0,00 | -40,6 -40,1 -1.13% | -15,8 -15,7 -0.15% | -16,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,1 -16,0 12.1% | -11,5 -11,9 3.53% | 0,00 | -37,7 -37,7 0.05% | 5,09 -10,2 149.86% | -4,27 |
|
Net income Million USD | Released Forecast Spread | -14,4 -15,8 9.23% | -11,5 -11,9 3.53% | 0,00 | -36,6 -37,1 1.39% | 5,53 -12,8 143.15% | -4,27 |
|
EPS USD | Released Forecast Spread | -0,82 -0,90 8.89% | -0,56 -0,58 4% | -0,31 | -0,94 -0,95 1.26% | 0,14 -0,32 144.44% | -0,10 |
| Announcement Date | 27/11/19 | 24/11/20 | 30/03/22 | 06/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,67 0,70 -4.86% | 0,67 0,70 -3.71% | 0,68 0,69 -1.52% | 0,68 0,71 -4.64% | 0,67 0,73 -9.18% | 0,67 0,70 -3.71% | 0,00 0,70 - | 0,00 0,00 - | 0,50 | 0,50 | 0,50 |
|
EBIT Million USD | Released Forecast Spread | -11,3 -11,0 -2.29% | -11,4 -9,60 -18.93% | -8,19 -9,57 14.46% | -9,74 -9,98 2.4% | -5,21 -10,9 52.22% | -3,79 -4,67 18.76% | -2,89 -3,85 24.86% | -3,88 -3,85 -0.7% | -3,80 | -4,40 | -5,60 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,7 -10,8 0.85% | -11,1 -9,50 -16.49% | -7,15 -10,4 31.18% | -8,74 -10,00 12.6% | -3,61 -10,1 64.25% | -1,31 -4,00 67.18% | -3,28 -3,55 7.49% | 13,3 -2,00 764.8% | -0,70 | -1,60 | -3,50 |
|
Net income Million USD | Released Forecast Spread | -10,4 -10,8 3.47% | -10,5 -9,50 -10.87% | -7,06 -9,87 28.44% | -8,54 -9,48 9.87% | -3,40 -10,1 66.39% | -1,19 -3,93 69.64% | -3,22 -3,40 5.24% | 13,3 -4,80 377.83% | -0,70 | -1,60 | -3,50 |
|
EPS USD | Released Forecast Spread | -0,27 -0,27 0% | -0,27 -0,25 -10.2% | -0,18 -0,25 28.95% | -0,22 -0,24 7.69% | -0,08 -0,25 67.35% | -0,03 -0,10 70% | -0,08 -0,09 7.7% | 0,33 -0,12 375% | -0,02 | -0,04 | -0,09 |
| Announcement Date | 12/05/22 | 10/08/22 | 10/11/22 | 06/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 06/03/24 | - | - | - |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Oramed Pharmaceuticals, Inc.
| 2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |
- Stock Market
- Equities
- ORMP Stock
- Stock
- Calendar Oramed Pharmaceuticals, Inc.
